![]() ![]() The majority of the women believed their chances of getting breast cancer was “very unlikely” but they did feel that having a mammogram would be beneficial. Almost half reported having annual mammograms the remainder reported having mammograms every two to three years, and some women never had a mammogram in their lifetime, despite being age 40 or older. They looked at mammography screening frequency, beliefs about breast cancer including perceived susceptibility, perceived benefits and perceived barriers to screening. Lynn College of Nursing researchers recently conducted a study in a sample of about 400 Black women receiving care at its nurse-led FAU/Northwest Community Health Alliance Community Health Center in West Palm Beach. Florida Atlantic University Christine E.Studies are underway in South Florida to learn more. Black women have a 40% higher death rate compared to white women, according to the American Cancer Society. Race may be affecting the late stages of breast cancer diagnosis. Xiao said that will require a clinical trial in humans which will take several years. The long-term goal is to develop a new therapeutic that is safe and effective. The researchers are refining the compound’s design to make it more of a drug so it can be tested in animal models. “These compounds act like matchmakers, bringing together two proteins so one can destroy the other one,” said Yufeng Xiao, the study’s co-first author. Only a small amount of the YX968 compound was needed. In laboratory testing in breast cancer cells, the compound, known as YX968, effectively targeted unwanted proteins in cancer cells and then degrading them - without harming healthy genes. A team of University of Florida medicinal chemists and cancer biologists has created a compound that can help cells dispose of proteins that cause cancer cells to grow. So far, Holy Cross has one patient participating and is screening three more for the trial.Ī chemical compound may help stop breast cancer in the earliest of stages. It also is evaluating the safety of the drug in men. If effective, this would reduce the risk of the breast cancer coming back. ![]() The trial is evaluating whether the medication suppresses ovarian estrogen production in premenopausal women who are undergoing chemotherapy. Oncologists at The Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Health in Fort Lauderdale are enrolling patients with HR+, HER2-negative breast cancer in a clinical trial for a drug made by Tolmar called TOL2506. Medication is evolving to better treat certain types of breast cancer and keep them from spreading. The team will apply artificial intelligence to construct computer models for personalizing treatment based on a patient’s tumor genetics. Mohammed Gbadamosi, a researcher in the University of Florida College of Pharmacy, has secured a $1.25 million grant to launch his own independent academic research laboratory and build a team focused on developing breast cancer treatment strategies. A team at University of Florida is studying whether the right combination of chemotherapy and immunotherapy can combat aggressive breast cancer and how AI can help. Artificial intelligence also is being studied for customized treatment. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |